Niederau W, Höffler U, Pulverer G
Infection. 1982;10(3):177-83. doi: 10.1007/BF01640772.
Reference data on the overall resistance patterns of anaerobic bacteria are needed since in individual clinical cases susceptibility testing is complicated by the long generation time and difficulties of test conditions. Benzylpenicillin and tetracyclines are the drugs of choice against Clostridium perfringens. Newer cephalosporins are also active, whereas other Clostridium species have been found resistant. Beta-lactam antibiotics show high activity against Peptococcaceae; resistance to clindamycin should be noted, however. The good in vitro activity of tetracyclines, clindamycin and erythromycin against Propionibacterium acnes could be confirmed in the systemic and local therapy of acne vulgaris. In contrast to gram-positive anaerobic bacteria, only some penicillin and cephalosporin derivatives are sufficiently active against gram-negative rods of the Bacteroides group. Sporadic resistance is seen to the newer tetrayclines, nitroimidazole compounds and to lincomycins. Nevertheless, these substances must be considered as standard therapeutics for infections caused by anaerobic gram-negative bacteria. It should be mentioned that cefoxitin may offer new therapeutic possibilities.
由于在个别临床病例中,厌氧细菌的药敏试验因代时较长和试验条件困难而变得复杂,因此需要有关厌氧细菌总体耐药模式的参考数据。苄青霉素和四环素是治疗产气荚膜梭菌的首选药物。新型头孢菌素也有活性,而其他梭菌属已被发现具有耐药性。β-内酰胺类抗生素对消化球菌科显示出高活性;然而,应注意对克林霉素的耐药性。四环素、克林霉素和红霉素对痤疮丙酸杆菌的良好体外活性已在寻常痤疮的全身和局部治疗中得到证实。与革兰氏阳性厌氧细菌不同,只有一些青霉素和头孢菌素衍生物对拟杆菌属革兰氏阴性杆菌有足够的活性。对新型四环素、硝基咪唑化合物和林可霉素存在散在耐药性。尽管如此,这些物质必须被视为厌氧革兰氏阴性细菌感染的标准治疗药物。应该提到的是,头孢西丁可能提供新的治疗可能性。